Sam Brusco, Associate Editor09.11.23
Zeta Surgical, a surgical robotics and mixed reality firm founded by Harvard graduates and faculty, has gained U.S. Food and Drug Administration (FDA) clearance for its Zeta cranial mixed reality surgical navigation system.
According to Zeta, the mixed reality surgical navigation system for neurosurgery offers “GPS-like” guidance with millimetric accuracy in real-time. Zeta’s computer vision engine maintains accuracy by automatically registering multiple times a second to account for patient movement.
The company said Zeta can be used in and out of the operating room to remove the need for general anesthesia and rigid skull immobilization.
Dr. William Gormley, chief medical officer of Zeta Surgical and Harvard Medical School Associate Professor, told the press, "The FDA's market clearance of the Zeta Navigation system ushers in the next generation of innovation to neurosurgery. Like all paradigm changing innovations, Zeta will change the way we conceive of where we can perform neurosurgery within our hospitals and where in the world these hospitals can be."
"Zeta Surgical has created a platform technology that not only improves existing techniques and workflows but also enables novel therapies, expanding the scope of treatment for neurologic diseases," added Dr. Kyle Wu, Director of Neurosurgical Innovation at The Ohio State University Wexner Medical Center.
"Not only can the Zeta platform be used to navigate the most complex cranial surgeries, but it can also enable more routine cranial surgeries to be done in lower cost settings outside of a traditional OR without the need for general anesthesia," said Dr. Matthew McGirt, Professor of Neurosurgery at Atrium Health-Wake Forest, and a Director at the Carolina Neurosurgery & Spine Associates. "Few technologies improve both quality and cost for hospital systems like Zeta does."
According to Zeta, the mixed reality surgical navigation system for neurosurgery offers “GPS-like” guidance with millimetric accuracy in real-time. Zeta’s computer vision engine maintains accuracy by automatically registering multiple times a second to account for patient movement.
The company said Zeta can be used in and out of the operating room to remove the need for general anesthesia and rigid skull immobilization.
Dr. William Gormley, chief medical officer of Zeta Surgical and Harvard Medical School Associate Professor, told the press, "The FDA's market clearance of the Zeta Navigation system ushers in the next generation of innovation to neurosurgery. Like all paradigm changing innovations, Zeta will change the way we conceive of where we can perform neurosurgery within our hospitals and where in the world these hospitals can be."
"Zeta Surgical has created a platform technology that not only improves existing techniques and workflows but also enables novel therapies, expanding the scope of treatment for neurologic diseases," added Dr. Kyle Wu, Director of Neurosurgical Innovation at The Ohio State University Wexner Medical Center.
"Not only can the Zeta platform be used to navigate the most complex cranial surgeries, but it can also enable more routine cranial surgeries to be done in lower cost settings outside of a traditional OR without the need for general anesthesia," said Dr. Matthew McGirt, Professor of Neurosurgery at Atrium Health-Wake Forest, and a Director at the Carolina Neurosurgery & Spine Associates. "Few technologies improve both quality and cost for hospital systems like Zeta does."